BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 35818653)

  • 21. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting.
    Hughes S; Troise O; Donaldson H; Mughal N; Moore LSP
    Clin Microbiol Infect; 2020 Oct; 26(10):1395-1399. PubMed ID: 32603803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bacterial infections in patients with COVID-19: the impact of procalcitonin testing on antibiotics prescription in the real world.
    Lui GC; Cheung CS; Yip TC; Lai MS; Li TC; Wong GL
    BMC Infect Dis; 2024 Jan; 24(1):106. PubMed ID: 38243171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibiotics Use in Hospitalised COVID-19 Patients in a Tertiary Care Centre: A Descriptive Cross-sectional Study.
    Thapa B; Pathak SB; Jha N; Sijapati MJ; Shankar PR
    JNMA J Nepal Med Assoc; 2022 Jul; 60(251):625-630. PubMed ID: 36705203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis.
    Langford BJ; So M; Raybardhan S; Leung V; Soucy JR; Westwood D; Daneman N; MacFadden DR
    Clin Microbiol Infect; 2021 Apr; 27(4):520-531. PubMed ID: 33418017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of Bacterial Coinfection in COVID-19 Patients Is a Missing Piece of the Puzzle in the COVID-19 Management in Indonesia.
    Prasetyoputri A
    ACS Infect Dis; 2021 Feb; 7(2):203-205. PubMed ID: 33502840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of immunosuppressive therapy on secondary infections and antimicrobial use in COVID-19 inpatients: a retrospective cohort study.
    Crook P; Logan C; Mazzella A; Wake RM; Cusinato M; Yau T; Ong YE; Planche T; Basarab M; Bicanic T
    BMC Infect Dis; 2023 Nov; 23(1):808. PubMed ID: 37978457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiology of bacterial co-infections and risk factors in COVID-19-hospitalized patients in Spain: a nationwide study.
    López-Herrero R; Sánchez-de Prada L; Tamayo-Velasco A; Lorenzo-López M; Gómez-Pesquera E; Sánchez-Quirós B; de la Varga-Martínez O; Gómez-Sánchez E; Resino S; Tamayo E; Álvaro-Meca A
    Eur J Public Health; 2023 Aug; 33(4):675-681. PubMed ID: 37087109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibiotic use during the first 6 months of COVID-19 pandemic in Iran: A large-scale multi-centre study.
    Salehi M; Khalili H; Seifi A; Davoudi H; Darazam IA; Jahangard-Rafsanjani Z; Mohammadnejad E; Heydari B; Siahkaly SJM; Tabarsi P; Kalantari S; Menshadi SAD; Babamahmoodi F; Khorvash F; Davarpanah MA; Soltani R; Yaghoobi MH; Anari SAM; Khodadadi J; Aliramezani A; Hantooshzadeh S; Naderi HR; Hajiabdolbaghi M; Elyasi S; Firouzabadi D; Kasgari HA; Roshanzamiri S; Ebrahimpour S
    J Clin Pharm Ther; 2022 Dec; 47(12):2140-2151. PubMed ID: 36054303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibiotic use in patients with Coronavirus disease 2019 (COVID-19): outcomes and associated factors.
    Milas S; Poncelet A; Buttafuoco F; Pardo A; Lali SE; Cherifi S
    Acta Clin Belg; 2022 Jun; 77(3):579-587. PubMed ID: 33896399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of rapid multiplex PCR on management of antibiotic therapy in COVID-19-positive patients hospitalized in intensive care unit.
    Maataoui N; Chemali L; Patrier J; Tran Dinh A; Le Fèvre L; Lortat-Jacob B; Marzouk M; d'Humières C; Rondinaud E; Ruppé E; Montravers P; Timsit JF; Armand-Lefèvre L
    Eur J Clin Microbiol Infect Dis; 2021 Oct; 40(10):2227-2234. PubMed ID: 33733394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of respiratory bacterial co-infection in hospitalized COVID-19 patients.
    Bolker A; Coe K; Smith J; Stevenson K; Wang SH; Reed E
    Diagn Microbiol Infect Dis; 2022 Jan; 102(1):115558. PubMed ID: 34731685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive model for bacterial co-infection in patients hospitalized for COVID-19: a multicenter observational cohort study.
    Giannella M; Rinaldi M; Tesini G; Gallo M; Cipriani V; Vatamanu O; Campoli C; Toschi A; Ferraro G; Horna CS; Bartoletti M; Ambretti S; Violante F; Viale P; Curti S
    Infection; 2022 Oct; 50(5):1243-1253. PubMed ID: 35488112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Distribution of Multidrug-resistant Microorganisms and Treatment Status of Hospital-acquired Pneumonia/Ventilator-associated Pneumonia in Adult Intensive Care Units: a Prospective Cohort Observational Study.
    Chang Y; Jeon K; Lee SM; Cho YJ; Kim YS; Chong YP; Hong SB
    J Korean Med Sci; 2021 Oct; 36(41):e251. PubMed ID: 34697926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is there a correlation between antibiotic use and the severity or post-infection conditions of COVID-19 and other viral infections?
    Au TY; Assavarittirong C; Benjamin S; Wiśniewski OW
    Clin Exp Med; 2023 Dec; 23(8):4123-4128. PubMed ID: 37653183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Empiric Antibacterial Therapy and Community-onset Bacterial Coinfection in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19): A Multi-hospital Cohort Study.
    Vaughn VM; Gandhi TN; Petty LA; Patel PK; Prescott HC; Malani AN; Ratz D; McLaughlin E; Chopra V; Flanders SA
    Clin Infect Dis; 2021 May; 72(10):e533-e541. PubMed ID: 32820807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibiotics in treatment of COVID-19 complications: a review of frequency, indications, and efficacy.
    Chedid M; Waked R; Haddad E; Chetata N; Saliba G; Choucair J
    J Infect Public Health; 2021 May; 14(5):570-576. PubMed ID: 33848886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discontinuation of Antibiotics in Patients with Neurological Conditions - A Study on the Impact of an Antimicrobial Stewardship Program (ASP) in a Tertiary Institution.
    Loo LW; Liew YX; Chlebicki P; Kwa AL
    Int J Antimicrob Agents; 2020 Aug; 56(2):106038. PubMed ID: 32479888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased antimicrobial resistance during the COVID-19 pandemic.
    Lai CC; Chen SY; Ko WC; Hsueh PR
    Int J Antimicrob Agents; 2021 Apr; 57(4):106324. PubMed ID: 33746045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secondary bacterial infections in patients with coronavirus disease 2019-associated pneumonia.
    Aydemir O; Aydemir Y; Şahin EÖ; Şahin F; Koroglu M; Erdem AF
    Rev Assoc Med Bras (1992); 2022 Feb; 68(2):142-146. PubMed ID: 35239872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Healthcare-associated
    Manea E; Jipa R; Milea A; Roman A; Neagu G; Hristea A
    Rom J Intern Med; 2021 Dec; 59(4):409-415. PubMed ID: 34053203
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.